Home/Tag: MSKCC

Potential Treatment for Imatinib-Resistant GIST Explored

Dr. Ron DeMatteo GIST specialist surgeon Dr. Ron DeMatteo, along with colleagues at Memorial Sloan-Kettering Cancer Center (MSKCC), has published a new paper in the April issue of Cancer Research with potentially [...]

By |2019-10-31T12:01:35-04:00June 16th, 2015|Drug Treatment, News, Research|

MSKCC Opens New Immunotherapy Trial for GIST

A new clinical trial combining targeted therapy with immunotherapy has just opened at Memorial Sloan-Kettering Cancer Center (MSKCC). This trial is the culmination of extensive pre-clinical investigations by MSKCC researchers. Although treatment with Gleevec [...]

By |2018-07-06T15:26:20-04:00August 1st, 2012|Clinical Trials, News|
Go to Top